🔎 Trials Near Me

Akèy › Kansè Endomèt › Minnesota › Rochester

Etid klinik pou Kansè Endomèt nan Rochester, MN

20 etid pou Kansè Endomèt ap chèche patisipan nan sit nan ak bò kote Rochester (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Ap rekriteFaz 2
  • Mayo Clinic in Rochester, Rochester
Tout laj · Tout sèks · Mizajou Oct 5, 2026 · NCT05564377

A Phase 1 Study of the Safety and Tolerability of CTX-10726

Ap rekriteFaz 1
  • Mayo Clinic Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT07419841

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Ap rekriteEtid obsèvasyon
  • Mayo Clinic, Rochester
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05051722

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • Mayo Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Ap rekriteEtid obsèvasyon
  • Mayo Clinic (Rochester), Rochester
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation Therapy

Ap rekrite
  • Mayo Clinic in Rochester, Rochester
Laj 21 ak plis · Fanm · Mizajou Aug 31, 2026 · NCT07662824

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Ap rekrite
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Fanm · Mizajou Aug 19, 2026 · NCT04567771

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic (Minnesota), Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04657068

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic in Rochester, Rochester
Laj 45 ak plis · Fanm · Mizajou Jul 9, 2026 · NCT07527143

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Ap rekriteFaz 1/2
  • Mayo Clinic - Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05377996

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Fanm · Mizajou Apr 13, 2026 · NCT07062016

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Ap rekriteFaz 1/2
  • Mayo Clinic, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Mar 27, 2026 · NCT06395519

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

Ap rekriteEtid obsèvasyon
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Mar 12, 2026 · NCT06349642

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT07407959

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Ap rekriteFaz 1
  • Mayo Clinic in Rochester, Rochester
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT05103683

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Mayo Clinic, Rochester
Laj 40 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366881

Etid Kansè Endomèt nan lòt vil

Lòt etid nan Rochester

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.